A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression
Clinical trial NCT05268497 · WITHDRAWN
Trial details
- NCT number
- NCT05268497
- Sponsor
- Janssen Research & Development, LLC
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-06-07
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.